Sildenafil decreased pulmonary arterial pressure but may have exacerbated portal hypertension in a patient with cirrhosis and portopulmonary hypertension

Journal of Gastroenterology

Volumn 41, Issue 6, 2006, Pages 593-597

  Wang, Ying Wen ^a   Lin, Han Chieh ^a   Yang, Ying Ying ^a   Hou, Ming Chih ^a   Lee, Shou Dong ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Cirrhosis; Liver transplantation; Portal hypertension; Primary pulmonary hypertension; Sildenafil

Indexed keywords

SILDENAFIL;

ADULT; ARTICLE; ASCITES; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE EXACERBATION; ECHOCARDIOGRAPHY; ECHOGRAPHY; ESOPHAGUS SURGERY; ESOPHAGUS VARICES; FOLLOW UP; HEPATITIS C; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LIVER BLOOD FLOW; LIVER CIRRHOSIS; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; MALE; MELENA; PORTAL HYPERTENSION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; THORAX RADIOGRAPHY;

ADULT; HUMANS; HYPERTENSION, PORTAL; HYPERTENSION, PULMONARY; LIVER CIRRHOSIS; MALE; PIPERAZINES; PURINES; SULFONES; VASODILATOR AGENTS;

EID: 33746488276     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-006-1809-y     Document Type: Article

References (31)

1. JR Runo JE Loyd 2003 Primary pulmonary hypertension Lancet 361 1533-44 12737878 10.1016/S0140-6736(03)13167-4
2. JW Strange J Wharton PG Phillips MR Wilkins 2002 Recent insights into the pathogenesis and therapeutics of pulmonary hypertension Clin Sci 102 253-68 11869166 10.1042/CS20010212
3. D Lebrec JP Capron D Dhumeaux JP Benhamou 1979 Pulmonary hypertension complicating portal hypertension Am Rev Respir Dis 120 849-56 159649 1:STN:280:Bi%2BD28zislA%3D
4. PJ McDonnell PA Toye GM Hutchins 1983 Primary pulmonary hypertension and cirrhosis: Are they related? Am Rev Respir Dis 127 437-41 6838050 1:STN:280:BiyC2snltl0%3D
5. JR Ruttner JP Bartschi R Niedermann J Schneider 1980 Plexogenic pulmonary arteriopathy and liver cirrhosis Thorax 35 133-6 7376117 1:STN:280:Bi%2BC1M3ksV0%3D
6. A Hadengue MK Benhayou D Lebrec JP Benhamou 1991 Pulmonary hypertension complicating portal hypertension: Prevalence and relation to splanchnic hemodynamics Gastroenterology 100 520-8 1985048 1:STN:280:By6D1crotFU%3D
7. YY Yang HC Lin WC Lee MC Hou FY Lee FY Chang et al. 2001 Portopulmonary hypertension: Distinctive hemodynamic and clinical manifestations J Gastroenterol 36 181-6 11291881 1:STN:280:DC%2BD38%2FgslCitA%3D%3D 10.1007/s005350170126
8. AE Michael B Ramsay R Simpson AT Nguyen KJ Ramsay C East et al. 1997 Severe pulmonary hypertension in liver transplant candidates Liver Transplant Surg 3 494-500
9. MJ Krowka DJ Plevak JY Findlay CB Rosen RH Wiesner RA Krom 2000 Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation Liver Transpl 6 443-50 10915166 1:STN:280:DC%2BD3M%2FitVOjtQ%3D%3D 10.1053/jlts.2000.6356
10. BD Robalino DS Moodie 1991 Association between primary pulmonary hypertension and portal hypertension: Analysis of its clinical, laboratory and hemodynamic manifestations J Am Coll Cardiol 17 492-8 1991908 1:STN:280:By6C38zlsl0%3D
11. PC Kuo LB Johnson JS Plotkin CD Howell ST Bartlett LJ Rubin 1997 Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension Transplantation 63 604-6 9047158 1:CAS:528:DyaK2sXhvFKqsL4%3D 10.1097/00007890-199702270-00020
12. MJ Krowka RP Frantz MD McGoon C Severson DJ Plevak RH Wiesner 1999 Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension Hepatology 30 641-8 10462369 1:CAS:528:DyaK1MXmtVSktrY%3D 10.1002/hep.510300307
13. M Guazzi G Tumminello F Di Marco MD Guazzi 2004 Influence of sildenafil on lung function and hemodynamics in patients with chronic heart failure Clin Pharmacol Ther 76 371-8 15470337 1:CAS:528:DC%2BD2cXotlCmtbw%3D 10.1016/j.clpt.2004.06.003
14. H Makisalo A Koivusalo A Vakkuri K Hockerstedt 2004 Sildenafil for portopulmonary hypertension in a patient undergoing liver transplantation Liver Transpl 10 945-50 15237383 10.1002/lt.20153
15. HC Lin YT Tsai FY Lee SD Lee HC Hsia WJ Lin et al. 1992 Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosis Gastroenterology 103 229-34 1612330 1:STN:280:By2A3cjivFw%3D
16. LJ Rubin 1997 Primary pulmonary hypertension N Engl J Med 336 111-7 8988890 1:STN:280:ByiC3s%2Fgs1w%3D 10.1056/NEJM199701093360207
17. RJ Barst M McGoon A Torbicki O Sitbon MJ Krowka H Olschewski et al. 2004 Diagnosis and differential assessment of pulmonary arterial hypertension J Am Coll Cardiol 43 40S-47S 15194177 10.1016/j.jacc.2004.02.032
18. S Provencher P Herve X Jais D Lebrec M Humbert G Simonneau et al. 2006 Deleterious effects of β-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension Gastroenterology 130 120-6 16401475 1:CAS:528:DC%2BD28XhtFCgtbs%3D 10.1053/j.gastro.2005.10.013
19. MM Hoeper MJ Krowka CP Strassburg 2004 Portopulmonary hypertension and hepatopulmonary syndrome Lancet 363 1461-8 15121411 10.1016/ S0140-6736(04)16107-2
20. M Castro MJ Krowka DR Schroeder KC Beck DJ Plevak SR Rettke et al. 1996 Frequency and clinical implications of increased pulmonary artery pressure in liver transplant patients Mayo Clin Proc 71 543-51 8642882 1:STN:280:BymB3s3is1A%3D
21. P Hervé D Lebrec F Brenot G Simonneau M Humbert O Sitbon et al. 1998 Pulmonary vascular disorder in portal hypertension Eur Respir J 11 1153-66 9648972 10.1183/09031936.98.11051153
22. A Lockhart 1985 Pulmonary arterial hypertension in portal hypertension Clin Gastroenterol 14 123-38 3987074 1:STN:280:BiqC2sjmtVM%3D
23. MS Mandell BM Groves 1996 Pulmonary hypertension in liver disease Clin Chest Med 17 17-33 8665788 1:STN:280:BymB2MvosFI%3D 10.1016/ S0272-5231(05)70296-3
24. S Rich E Kaufmann PS Levy 1992 The effect of high doses of calcium channel blockers on survival in primary pulmonary hypertension N Engl J Med 327 76-81 1603139 1:STN:280:By2B1Mzislc%3D
25. JA Beavo 1995 Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms Physiol Rev 75 725-48 7480160 1:CAS:528:DyaK28XlvVyj
26. RM Wallis JD Corbin SH Francis P Ellis 1999 Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro Am J Cardiol 83 3C-12C 10078537 1:CAS:528:DyaK1MXitFWnt7k%3D 10.1016/S0002-9149(99)00042-9
27. HS Ahn M Foster M Cable BJ Pitts EJ Sybertz 1991 Ca/CaM-stimulated and cGMP-specific phosphodiesterases in vascular and non-vascular tissues Adv Exp Med Biol 308 191-7 1666264 1:CAS:528:DyaK38XitlamsLc%3D
28. P Medina G Segarra JB Martinez-Leon JM Vila M Aldasoro E Otero et al. 2000 Relaxation induced by cGMP phosphodiesterase inhibitors sildenafil and zaprinast in human vessels Ann Thorac Surg 70 1327-31 11081893 1:STN:280:DC%2BD3M%2FjvFOquw%3D%3D 10.1016/S0003-4975(00)01914-7
29. G Jackson N Benjamin N Jackson MJ Allen 1999 Effects of sildenafil citrate on human hemodynamics Am J Cardiol 83 13C-20C 10078538 1:CAS:528:DyaK1MXitFWnt7Y%3D 10.1016/S0002-9149(99)00043-0
30. T Charalabos C Ageliki D Spiros 2002 Sildenafil (Viagra) is a risk factor for acute variceal bleeding Am J Gastroenterol 97 1856
31. I Colle AS De Vriese H Van Vlierberghe NH Lameire M De Vos 2004 Systemic and splanchnic haemodynamic effects of sildenafil in an in vivo animal model of cirrhosis support for a risk in cirrhotic patients Liver Int 24 63-8 15102002 1:CAS:528:DC%2BD2cXjtFejsb4%3D 10.1111/ j.1478-3231.2004.00892.x